🍄 Quick Summary The benefits of microdosing mushrooms are widely discussed in relation to mood, creativity, and cognitive flexibility. While many reports are anecdotal, researchers are beginning to explore how small doses of psilocybin may influence brain function and emotional processing. Introduction The benefits of microdosing mushrooms have become one of the most talked-about topics […]
Monthly Archives: March 2026
🍄 Quick Summary Microdosing Schedule Explained (Fadiman vs Stamets) (2026) Introduction A microdosing schedule is one of the most important aspects of understanding how microdosing is discussed in psychedelic education. Rather than focusing only on the amount taken, schedules define how often doses are spaced over time. Interest in microdosing routines has grown as researchers […]
🍄 Quick Summary : A psilocybin dosage chart helps explain the differences between microdoses, low doses, moderate doses, and higher psychedelic doses. Understanding dosage ranges is important for education, harm reduction awareness, and psychedelic research discussions. Introduction Understanding psilocybin dosage is one of the most important topics when learning about psychedelic mushrooms. Different dosage levels […]
🍄 Quick Summary Psilocybin microdosing refers to taking very small amounts of psychedelic mushrooms to explore subtle psychological effects without experiencing a full psychedelic trip. Interest in this practice has grown significantly, although scientific research is still developing. Introduction Psilocybin microdosing has become one of the most widely discussed topics in modern psychedelic science. Instead […]
Legal and Advocacy, MICRODOSING, Science and Reserach
What Is Ibogaine? Effects, Research & 2026 Legal Status
17
Mar
Mar
🍄 Quick Summary Ibogaine is a plant-derived psychedelic from the West African Tabernanthe iboga shrub that has shown remarkable results for opioid addiction, PTSD, and traumatic brain injury in early research. It remains Schedule I in the United States, but Texas has allocated $50 million for clinical research, Stanford published landmark veteran data in 2024–2025, […]
15
Mar
Mar
🍄 Quick Summary Microdosing psilocybin for anxiety is the most common reason people start the practice — and the evidence is genuinely encouraging. Large observational studies show consistent anxiety and stress reductions in microdosers. Controlled trials are more cautious. Dose, protocol, and product quality determine most of the outcome. Introduction Microdosing psilocybin for anxiety is […]
15
Mar
Mar
🍄 Quick Summary Lion’s mane mushroom for brain health is backed by real science — but the evidence is more nuanced than most supplement labels suggest. It contains unique compounds that stimulate nerve growth factor production in the brain, with the strongest clinical evidence in older adults and people with mild cognitive impairment. Results in […]
09
Mar
Mar
🍄 Quick Summary Psilocybin is fully legal for supervised therapeutic use in Oregon and Colorado. It is decriminalized at the city or county level in over 20 US municipalities. New Mexico allows personal cultivation under a court ruling. Research-based access is expanding across a dozen states. Everywhere else, psilocybin remains a Schedule I controlled substance […]
08
Mar
Mar
🍄 Quick Summary Psychedelic therapy in 2026 costs between $1,500 and $12,000 depending on the compound, provider, and location — and insurance covers almost none of it. Psilocybin therapy in Oregon or Colorado runs $3,500–$5,000 per treatment plan. Ketamine is the most accessible at $2,400–$4,800 for a full course. Clinical trials offer free access for […]
08
Mar
Mar
🍄 Quick Summary A landmark 2025 study from Ohio State University and Johns Hopkins tracked 18 patients for an average of 5.37 years after psilocybin-assisted therapy for major depression. At follow-up, 67% were in clinical remission — with improvements in anxiety, functioning, and quality of life across every measure. Two doses of psilocybin, paired with […]
- 1
- 2